Zur Programmübersicht
Vortrag
How big pharma business model is a gamer changer for the PE market
28.02.2023 von 14:20 - 14:40
ICM Saal 13b
Sprache: Englisch
Vortragsart: Oral Presentation
Vortragsbeschreibung
GenesInk has changed its business model to speed up PE developments by proposing fine-tuned solutions and licensing contract which let to customer better TCO management.
This presentation will explain how this new business model is a game changer for the PE market by going through the following points :
- GenesInk as an externalized R&D center
- Partnership with technical centers
- Inks licensing
Loading...